FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on: April 28,2024

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on:April 28,2024

Mathematics supporting fresh theoretical approach in oncology

byUniversity of the Basque CountryMathematics, histopathology and genomics converge to confirm that highly aggressive clear cell renal cell carcinomas display low levels of intratumour heterogen

Updated on: January 26,2024

Mathematics supporting fresh theoretical approach in oncology

byUniversity of the Basque CountryMathematics, histopathology and genomics converge to confirm that highly aggressive clear cell renal cell carcinomas display low levels of intratumour heterogen

Updated on:January 26,2024

A case for routine evaluation of HER2 expression in ductal carcinoma in situ

by Impact JournalsCredit: Unsplash/CC0 Public DomainA new editorial paper was published inOncoscienceand is titled "HER2 expression should be routinely evaluated in DCIS to avoid unde

Updated on: December 20,2023

A case for routine evaluation of HER2 expression in ductal carcinoma in situ

by Impact JournalsCredit: Unsplash/CC0 Public DomainA new editorial paper was published inOncoscienceand is titled "HER2 expression should be routinely evaluated in DCIS to avoid unde

Updated on:December 20,2023

Prostate cancer can now be diagnosed better using artificial intelligence

byRadboud UniversityMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Radboud university medical cen

Updated on: December 22,2023

Prostate cancer can now be diagnosed better using artificial intelligence

byRadboud UniversityMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Radboud university medical cen

Updated on:December 22,2023

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col

Updated on: December 22,2023

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col

Updated on:December 22,2023

How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

by Niyati Jain,University of ChicagoDifferential expression of gene pathways in BCC (in blue) compared to healthy skin tissue (in red) by PTCH1 mutational status. BCC tissues with no non-synonym

Updated on: December 01,2024

How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

by Niyati Jain,University of ChicagoDifferential expression of gene pathways in BCC (in blue) compared to healthy skin tissue (in red) by PTCH1 mutational status. BCC tissues with no non-synonym

Updated on:December 01,2024

All in the blood: New way to detect drug resistance in ovarian cancer patients

byWalter and Eliza Hall InstituteThe "splicing" mechanism in cancer cells allows them to repair their DNA and avoid the cell death caused by PARP inhibitor therapy, resulting in drug r

Updated on: December 02,2024

All in the blood: New way to detect drug resistance in ovarian cancer patients

byWalter and Eliza Hall InstituteThe "splicing" mechanism in cancer cells allows them to repair their DNA and avoid the cell death caused by PARP inhibitor therapy, resulting in drug r

Updated on:December 02,2024

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

byAmerican Society for Radiation OncologyCombinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial

Updated on: December 18,2023

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

byAmerican Society for Radiation OncologyCombinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial

Updated on:December 18,2023

Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation

by University of TsukubaCredit: Unsplash/CC0 Public DomainAllogeneic hematopoietic stem-cell transplantation (allo-HSCT) can cure hematopoietic diseases, such as acute myeloid leukemia. Cord bloo

Updated on: April 24,2024

Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation

by University of TsukubaCredit: Unsplash/CC0 Public DomainAllogeneic hematopoietic stem-cell transplantation (allo-HSCT) can cure hematopoietic diseases, such as acute myeloid leukemia. Cord bloo

Updated on:April 24,2024

Researchers find genetic variant contributing to disparities in childhood leukemia risk

by Keck School of Medicine of USCCredit: CC0 Public DomainAcute lymphoblastic leukemia (ALL), the most common childhood cancer, disproportionately affects children of Hispanic/Latino origin in th

Updated on: March 27,2024

Researchers find genetic variant contributing to disparities in childhood leukemia risk

by Keck School of Medicine of USCCredit: CC0 Public DomainAcute lymphoblastic leukemia (ALL), the most common childhood cancer, disproportionately affects children of Hispanic/Latino origin in th

Updated on:March 27,2024

Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an

Updated on: December 22,2023

Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an

Updated on:December 22,2023

Mobile 'Man Van' spots prostate cancer more quickly and cheaply than via GPs

byInstitute of Cancer ResearchCredit: The Man Van and The Royal Marsden NHS Foundation TrustMobile testing "Man Van" can diagnose prostate cancer in at-risk groups earlier and more aff

Updated on: December 01,2024

Mobile 'Man Van' spots prostate cancer more quickly and cheaply than via GPs

byInstitute of Cancer ResearchCredit: The Man Van and The Royal Marsden NHS Foundation TrustMobile testing "Man Van" can diagnose prostate cancer in at-risk groups earlier and more aff

Updated on:December 01,2024